Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases

Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...
IEEE

Multi-Objective Genetic Programming Assisted Stochastic Deep Reinforcement Learning for Dynamic Knowledge Integration in Transportation Networks

Abstract: Transportation Networks (TNs) play a critical role in economic and social systems, yet the dynamic nature and inherent heterogeneity of TN data pose challenges for Dynamic Knowledge ...